These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 4050430)

  • 1. Maple syrup urine disease variant form: presentation with psychomotor retardation and CT scan abnormalities.
    Verdu A; Lopez-Herce J; Pascual-Castroviejo I; Martinez-Bermejo A; Ugarte M; Garcia MJ
    Acta Paediatr Scand; 1985 Sep; 74(5):815-8. PubMed ID: 4050430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlations between branched-chain amino acids and branched-chain alpha-keto acids in blood in maple syrup urine disease.
    Langenbeck U; Wendel U; Mench-Hoinowski A; Kuschel D; Becker K; Przyrembel H; Bremer HJ
    Clin Chim Acta; 1978 Sep; 88(2):283-91. PubMed ID: 699323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CT and MRI in maple syrup urine disease.
    Uziel G; Savoiardo M; Nardocci N
    Neurology; 1988 Mar; 38(3):486-8. PubMed ID: 3347354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between the branched chain amino acids and their alpha-ketoacids in maple syrup urine disease.
    Snyderman SE; Goldstein F; Sansaricq C; Norton PM
    Pediatr Res; 1984 Sep; 18(9):851-3. PubMed ID: 6483508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebral computed tomography in maple syrup urine disease.
    Romero FJ; Ibarra B; Rovira M; Natal A; Herrera M; Segarra A
    J Comput Assist Tomogr; 1984 Jun; 8(3):410-1. PubMed ID: 6609940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cranial computed tomography in a patient with a variant form of maple syrup urine disease.
    Suzuki S; Naito H; Abe T; Nihei K
    Neuropediatrics; 1983 May; 14(2):102-3. PubMed ID: 6877525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computed tomography findings in maple syrup urine disease.
    Ong LC; Khoo TB; Zulfiqar A; Zarida H; Ruzana A
    Singapore Med J; 1998 Aug; 39(8):370-2. PubMed ID: 9844500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maple syrup urine disease: interrelations between branched-chain amino-, oxo- and hydroxyacids; implications for treatment; associations with CNS dysmyelination.
    Treacy E; Clow CL; Reade TR; Chitayat D; Mamer OA; Scriver CR
    J Inherit Metab Dis; 1992; 15(1):121-35. PubMed ID: 1583867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peritoneal dialysis in maple-syrup-urine disease: studies on branched-chain amino and keto acids.
    Wendel U; Becker K; Przyrembel H; Bulla M; Manegold C; Mench-Hoinowski A; Langenbeck U
    Eur J Pediatr; 1980 Jun; 134(1):57-63. PubMed ID: 7408911
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cranial computed tomography in maple syrup urine disease].
    Irnberger T; Plöchl E; Rittinger O; Bachmann C; Pilz P; Walter GF; Wendel U
    Rofo; 1986 Apr; 144(4):413-7. PubMed ID: 3008253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical phenotype in a boy with a maple syrup urine disease.
    Ben-Omran TI; Blaser S; Phillips H; Callahan J; Feigenbaum A
    J Inherit Metab Dis; 2006 Feb; 29(1):195-200. PubMed ID: 16601891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maple syrup urine disease (branched-chain keto-aciduria) variant type manifesting as hyperkinetic behaviour and mental retardation. Report of two cases.
    Kalyanaraman K; Chamukuttan S; Arjundas G; Gajanan N; Ramamurthi B
    J Neurol Sci; 1972 Feb; 15(2):209-17. PubMed ID: 5010106
    [No Abstract]   [Full Text] [Related]  

  • 13. Thiamine response in maple syrup urine disease.
    Fernhoff PM; Lubitz D; Danner DJ; Dembure PP; Schwartz HP; Hillman R; Bier DM; Elsas LJ
    Pediatr Res; 1985 Oct; 19(10):1011-6. PubMed ID: 3903643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysmyelination in the brain of adolescents and young adults with maple syrup urine disease.
    Schönberger S; Schweiger B; Schwahn B; Schwarz M; Wendel U
    Mol Genet Metab; 2004 May; 82(1):69-75. PubMed ID: 15110325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma amino acid analyses in two cases of maple syrup urine disease.
    Surarit R; Srisomsap C; Wasant P; Svasti J; Suthatvoravut U; Chokchaichamnankit D; Liammongkolkul S
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():138-9. PubMed ID: 11400750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of (S)- and (R)-2-oxo-3-methylvaleric acid in plasma of patients with maple syrup urine disease.
    Wendel U; Even G; Langenbeck U; Schadewaldt P; Hummel W
    Clin Chim Acta; 1992 Jun; 208(1-2):85-91. PubMed ID: 1638756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computed tomography in maple syrup urine disease.
    Taccone A; Schiaffino MC; Cerone R; Fondelli MP; Romano C
    Eur J Radiol; 1992; 14(3):207-12. PubMed ID: 1563430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis and treatment of maple syrup disease: a study of 36 patients.
    Morton DH; Strauss KA; Robinson DL; Puffenberger EG; Kelley RI
    Pediatrics; 2002 Jun; 109(6):999-1008. PubMed ID: 12042535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exchange transfusion in acute episodes of maple syrup urine disease. Studies on branched-chain amino and keto acids.
    Wendel U; Langenbeck U; Lombeck I; Bremer HJ
    Eur J Pediatr; 1982 Jul; 138(4):293-6. PubMed ID: 7128634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maple-syrup-urine disease.
    Wendel U; Lombeck I; Bremer HJ
    N Engl J Med; 1983 May; 308(18):1100-1. PubMed ID: 6835327
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.